Ullrich congenital muscular dystrophy
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Ullrich congenital muscular dystrophy | |
|---|---|
| |
| Synonyms | UCMD |
| Pronounce | |
| Specialty | Neurology, Genetics |
| Symptoms | Muscle weakness, joint hypermobility, contractures |
| Complications | N/A |
| Onset | Congenital |
| Duration | Lifelong |
| Types | N/A |
| Causes | Mutations in the COL6A1, COL6A2, or COL6A3 genes |
| Risks | Family history of the condition |
| Diagnosis | Genetic testing, muscle biopsy |
| Differential diagnosis | Bethlem myopathy, congenital muscular dystrophy |
| Prevention | N/A |
| Treatment | Physical therapy, orthopedic surgery, respiratory support |
| Medication | N/A |
| Prognosis | Variable, depending on severity |
| Frequency | Rare |
| Deaths | N/A |
Ullrich congenital muscular dystrophy (UCMD) is a rare genetic disorder characterized by muscle weakness and joint abnormalities. It is one of the forms of congenital muscular dystrophy, a group of muscle diseases that are present at birth or in early infancy.
Etiology[edit]
UCMD is caused by mutations in the genes that encode for collagen VI, a protein that is essential for the structural integrity of muscle tissue. The specific genes involved are COL6A1, COL6A2, and COL6A3. These mutations lead to defects in the collagen VI protein, resulting in muscle weakness and other symptoms associated with the disorder.
Clinical Features[edit]
Individuals with UCMD typically present with muscle weakness that is evident at birth or in early childhood. The muscle weakness is often accompanied by joint contractures, which are limitations in the range of motion of the joints. Other common features include:
- Hypotonia (decreased muscle tone)
- Hyperlaxity (increased flexibility) of distal joints
- Kyphoscoliosis (curvature of the spine)
- Respiratory difficulties due to weakness of the respiratory muscles
- Skin changes such as keratosis pilaris
Diagnosis[edit]
The diagnosis of UCMD is based on clinical examination, family history, and genetic testing. Muscle biopsy may show characteristic changes, and immunohistochemical staining can reveal abnormalities in collagen VI. Genetic testing can confirm mutations in the COL6A1, COL6A2, or COL6A3 genes.
Management[edit]
There is currently no cure for UCMD, and treatment is primarily supportive. Management strategies include:
- Physical therapy to maintain mobility and prevent contractures
- Orthopedic interventions for joint deformities
- Respiratory support, such as non-invasive ventilation, for individuals with respiratory muscle weakness
- Regular monitoring by a multidisciplinary team including neurologists, pulmonologists, and orthopedic specialists
Prognosis[edit]
The prognosis for individuals with UCMD varies depending on the severity of the condition. Some individuals may have a relatively stable course, while others may experience progressive muscle weakness and respiratory complications. Early intervention and supportive care can improve quality of life and functional outcomes.
